Bodyflight Sweden AB (publ) (XSAT:BODY)

Bodyflight Sweden AB Statistics

Total Valuation

XSAT:BODY has a market cap or net worth of SEK 10.89 million. The enterprise value is 24.26 million.

Market Cap	10.89M
Enterprise Value	24.26M

Important Dates

The next estimated earnings date is Monday, November 24, 2025.

Earnings Date	Nov 24, 2025
Ex-Dividend Date	n/a

Share Statistics

XSAT:BODY has 16.75 million shares outstanding.

Current Share Class	16.75M
Shares Outstanding	16.75M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	16.90%
Owned by Institutions (%)	n/a
Float	9.98M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.43
PB Ratio	0.21
P/TBV Ratio	0.22
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.99
EV / Sales	0.96
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.69

Financial Position

The company has a current ratio of 0.29, with a Debt / Equity ratio of 0.28.

Current Ratio	0.29
Quick Ratio	0.21
Debt / Equity	0.28
Debt / EBITDA	65.37
Debt / FCF	-1.60
Interest Coverage	-2.37

Financial Efficiency

Return on equity (ROE) is -9.10% and return on invested capital (ROIC) is -3.01%.

Return on Equity (ROE)	-9.10%
Return on Assets (ROA)	-2.20%
Return on Invested Capital (ROIC)	-3.01%
Return on Capital Employed (ROCE)	-4.33%
Revenue Per Employee	1.41M
Profits Per Employee	-270,278
Employee Count	20
Asset Turnover	0.28
Inventory Turnover	73.25

Taxes

Income Tax	-58,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -45.38% in the last 52 weeks. The beta is 0.55, so XSAT:BODY's price volatility has been lower than the market average.

Beta (5Y)	0.55
52-Week Price Change	-45.38%
50-Day Moving Average	0.60
200-Day Moving Average	0.83
Relative Strength Index (RSI)	49.64
Average Volume (20 Days)	21,714

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, XSAT:BODY had revenue of SEK 25.35 million and -4.87 million in losses. Loss per share was -0.29.

Revenue	25.35M
Gross Profit	12.35M
Operating Income	-3.23M
Pretax Income	-5.06M
Net Income	-4.87M
EBITDA	221,000
EBIT	-3.23M
Loss Per Share	-0.29

Balance Sheet

The company has 1.07 million in cash and 14.45 million in debt, giving a net cash position of -13.38 million or -0.80 per share.

Cash & Cash Equivalents	1.07M
Total Debt	14.45M
Net Cash	-13.38M
Net Cash Per Share	-0.80
Equity (Book Value)	51.53M
Book Value Per Share	3.08
Working Capital	-10.64M

Cash Flow

In the last 12 months, operating cash flow was -4.67 million and capital expenditures -4.36 million, giving a free cash flow of -9.03 million.

Operating Cash Flow	-4.67M
Capital Expenditures	-4.36M
Free Cash Flow	-9.03M
FCF Per Share	-0.54

Margins

Gross margin is 48.72%, with operating and profit margins of -12.74% and -19.19%.

Gross Margin	48.72%
Operating Margin	-12.74%
Pretax Margin	-19.94%
Profit Margin	-19.19%
EBITDA Margin	0.87%
EBIT Margin	-12.74%
FCF Margin	n/a

Dividends & Yields

XSAT:BODY does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-44.69%
FCF Yield	-82.98%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

XSAT:BODY has an Altman Z-Score of 1.03 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.03
Piotroski F-Score	2